Replies to post #7676 on LadRx Corp (LADXD)

[RodinLP]

Finally CYTR arrived to broke $1, but we're very far from R/S price $2,4 or from expectations of Aldoxorubicin phase3 in Summer of 2017, when Soon-Shiong jumped in at $6.6! Maybe next year something bigger could happen with Aldox and Aromoclomol.